Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of reports that a COVID-19 placenta-based cell therapy, developed in Israel, has had a 100 per cent survival rate during clinical trials.

The Department has noted the findings from this study. The Therapeutics Taskforce is continuing to monitor any new, high quality evidence on COVID-19 therapeutics.